View Brexit and the end of the transition period

Brexit and the end of the transition period

EU rules will no longer apply to most of the UK from 31st December 2020. But it’s not that simple! …

Read more

View Scientific Advice through the EMA Regulatory & Scientific Information Management Platform from October 19th 2020

Scientific Advice through the EMA Regulatory & Scientific Information Management Platform from October 19th 2020

From October 19th this year, Scientific Advice applications will need to go through the EMA Regulatory and Scientific Information Platform …

Read more

View The Changing Face of Pharma Communications Online Forum

The Changing Face of Pharma Communications Online Forum

We at Agos are looking forward to this online gathering of selected senior industry colleagues and expert guests from the …

Read more

View SME in Europe

SME in Europe

Agos Pharma have just renewed the SME status of our Irish subsidiary. This means we can access the excellent benefits …

Read more

View Borderline Medicines and Medical Devices

Borderline Medicines and Medical Devices

A number of our USA clients have come to us for help in Europe when developing a medicinal product or …

Read more

View Update on Clinical Trial Regulation “Application”

Update on Clinical Trial Regulation “Application”

The Clinical Trials Regulation will not be applied, and the Clinical Trial Directive will not be repealed, until full functionality …

Read more

View Brexit: USA-based testing can replace UK- (or EU-) based importation testing

Brexit: USA-based testing can replace UK- (or EU-) based importation testing

You no longer need to re-test certain pharmaceutical products imported from the USA to the EEA. This is due to …

Read more

View Agos Pharma announce their Bridge to Europe™ service

Agos Pharma announce their Bridge to Europe™ service

I am delighted to announce the Agos Pharma Bridge to Europe™ service which enables pharma and biotech companies to develop …

Read more